Vyome (HIND) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Dec, 2025Executive summary
Special meeting scheduled for April 1, 2025, to be held virtually, with record date set as February 18, 2025.
Three key proposals: reverse stock split, warrant exercise approval, and equity line of credit (ELOC) share issuance.
Board recommends voting FOR all proposals; voting can be done online, by phone, or by mail.
Quorum requires one-third of voting power present or represented by proxy.
Voting matters and shareholder proposals
Proposal 1: Authorize Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-250, at Board's discretion within one year.
Proposal 2: Approve exercisability of 2,703,862 warrants and issuance of up to 15,132,975 shares, with a zero exercise price option, issued in a February 2025 offering.
Proposal 3: Approve issuance of up to 15,000,000 shares under a $5,000,000 ELOC agreement over 36 months.
Shares held by certain investors on the record date are excluded from voting on related proposals.
All proposals require a majority of votes cast or represented at the meeting; abstentions count as votes against Proposals 2 and 3.
Board of directors and corporate governance
Board retains discretion to implement or abandon the reverse stock split within one year of approval.
Board may select the split ratio based on market conditions and other relevant factors.
Board can issue preferred stock with rights senior to common stock without further stockholder vote.
Stockholders can communicate with the Board via mail addressed to the company secretary.
Latest events from Vyome
- Net loss increased to $10.5M in 2025; cash runway to June 2027, further funding required.HIND
Q4 202518 Mar 2026 - Shareholders will vote on directors, an equity plan, auditor ratification, and executive pay.HIND
Proxy Filing15 Dec 2025 - Shareholders to vote on reverse split, warrant exercise, and ELOC issuance to support listing and capital needs.HIND
Proxy Filing15 Dec 2025 - Shareholders to vote on reverse split, warrant exercise, and ELOC share issuance for Nasdaq compliance.HIND
Proxy Filing15 Dec 2025 - $5.7M cash, $9.2M net loss, positive VT-1953 data, and 2026 regulatory plans for VT-1908.HIND
Q3 202520 Nov 2025